Subsidiary of Sailong Pharmaceutical Group (002898.SZ) receives approval notice for the listing application of chemical raw material drug acesolol hydrochloride
Sailong Pharmaceutical (002898.SZ) announces that its wholly-owned subsidiary, Hunan Sailong Pharmaceutical Co., Ltd., recently obtained...
Sailong Pharmaceutical Group (002898.SZ) announced that its wholly-owned subsidiary, Hunan Sailong Pharmaceutical Group Co., Ltd., recently received approval from the National Medical Products Administration for the issuance of the approval notification for the listing application of Atenolol hydrochloride as a chemical raw material. Atenolol hydrochloride formulations are mainly used for the treatment of paroxysmal supraventricular tachycardia or non-compensatory sinus tachycardia, intraoperative and postoperative tachycardia, and/or hypertension.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
